EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epac activation reduces trans-endothelial migration of undifferentiated neuroblastoma cells and cellular differentiation with a CDK inhibitor further enhances Epac effect

Rabiu Fage Inuwa, Diana Moss, John Quayle, Rasha Swadi iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Rabiu Fage Inuwa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, …. Hauptthemen laut MEDLINE: Guanine Nucleotide Exchange Factors, Neuroblastoma, Cell Differentiation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayero University Kano, Alder Hey Children's NHS Foundation Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma (NB) is the most common solid extracranial neoplasm found in children and is derived from primitive sympathoadrenal neural precursor. The disease accounts for 15% of all cancer deaths in children. The mortality rate is high in patients presenting with a metastatic tumour even with extensive treatments. This signifies the need for further research towards the development of new additional therapies that can combat not only tumour growth but metastasis, especially amongst the high-risk groups. During metastasis, primary tumour cells become migratory and travel towards a capillary within the tumour. They then degrade the matrix surrounding the pericytes and endothelial cells traversing the endothelial barrier twice to establish a secondary. This led to the hypothesis that modulation of the endothelial cell junctional stability could have an influence on tumour metastasis. To test this hypothesis, agents that modulate endothelial permeability on NB cell line migration and invasion were assessed in vitro in a tissue culture model. The cAMP agonist and its antagonists were found to have no obvious effect on both SK-N-BE2C and SK-N-AS migration, invasion and proliferation. Next, NB cells were cocultured with HDMEC cells and live cell imaging was used to assess the effect of an Epac agonist on trans-endothelial cell migration of NB cells. Epac1 agonist remarkably reduced the trans-endothelial migration of both SK-N-BE2C and SK-N-AS cells. These results demonstrate that an Epac1 agonist may perhaps serve as an adjuvant to currently existing therapies for the high-risk NB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guanine Nucleotide Exchange FactorsNeuroblastomaCell DifferentiationHumansCell Line, TumorProtein Kinase InhibitorsCell MovementTransendothelial and Transepithelial MigrationEndothelial CellsCyclic AMP

Substanzen

Guanine Nucleotide Exchange FactorsRAPGEF3 protein, humanProtein Kinase InhibitorsCyclic AMP

Autor:innen und Institutionen

  • Department of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Faculty of Basic Medical Sciences, Department of Anatomy, College of Health Sciences, Bayero University, Kano, Nigeria.
  • ALESS/ALESA Program, Center for Global Communication Strategies, Center for Global Education, University of Tokyo, Bunkyō, Japan.
  • School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
  • Institute for Health Research, Liverpool John Moores University, Liverpool, United Kingdom.

ORCID-Profile: Rasha Swadi

Förderung

  • Bayero University Kano
  • Alder Hey Children's NHS Foundation Trust

Zitieren

APA

Inuwa, R. F., Moss, D., Quayle, J., & Swadi, R. (2024). Epac activation reduces trans-endothelial migration of undifferentiated neuroblastoma cells and cellular differentiation with a CDK inhibitor further enhances Epac effect. PLOS ONE. https://doi.org/10.1371/journal.pone.0304547

Vancouver

Inuwa RF, Moss D, Quayle J, Swadi R. Epac activation reduces trans-endothelial migration of undifferentiated neuroblastoma cells and cellular differentiation with a CDK inhibitor further enhances Epac effect. PLOS ONE. 2024. doi:10.1371/journal.pone.0304547

BibTeX
@article{Inuwa2024,
  author = {Inuwa, Rabiu Fage and Moss, Diana and Quayle, John and Swadi, Rasha},
  title = {Epac activation reduces trans-endothelial migration of undifferentiated neuroblastoma cells and cellular differentiation with a CDK inhibitor further enhances Epac effect},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304547}
}
Kostenlos starten →